Bimekizumab Safe and Effective for Moderate-To-Severe Hidradenitis Suppurativa Treatment
1. Significantly more patients in the bimekizumab group than placebo reported improved clinical...
Read MoreJun 15, 2024
1. Significantly more patients in the bimekizumab group than placebo reported improved clinical...
Read MoreJun 14, 2024
1. Across a median follow-up of 48.5 months, usage of tebentafusp for patients with metastatic...
Read MoreJun 14, 2024
1. In this randomized controlled trial, among patients with centrosomal protein 290...
Read MoreJun 13, 2024
1. In this randomized controlled trial, 80 mg of olezarsen, but not 50 mg, significantly reduced...
Read MoreJun 13, 2024
1. In this randomized controlled trial, aficamten significantly improved peak oxygen uptake in...
Read MoreJun 13, 2024
1. Women in the surgical group reported 2.5 times more spontaneous ovulations than in medical...
Read MoreJun 13, 2024
1. Management of pediatric ulcerative colitis with tofacitinib successfully induced...
Read MoreJun 12, 2024
1. In this randomized controlled trial, in patients with hypertriglyceridemia and elevated...
Read MoreJun 12, 2024
1. In this randomized controlled trial, long-term calcium and vitamin D (CaD) supplementation was...
Read MoreJun 12, 2024
1. In this randomized controlled trial, adults with mixed hyperlipidemia who received zodasiran...
Read MoreJun 11, 2024
1. In this randomized controlled trial, among individuals with congenital thrombotic...
Read MoreJun 11, 2024
1. Asciminib demonstrated higher efficacy for the treatment of newly diagnosed CML than imatinib...
Read MoreJun 11, 2024
1. In this cohort study, within the pre-pandemic period, persons of Puerto Rican and Cuban...
Read MoreJun 11, 2024
1. The event-free survival at 12 months was 83.7% in the neoadjuvant group vs 57.2% in the...
Read MoreJun 8, 2024
1. In this randomized controlled trial, compared to culprit-lesion-only percutaneous coronary...
Read MoreJun 8, 2024
1. In this retrospective cohort study, among patients with type 2 diabetes (T2D) and stage five...
Read MoreJun 7, 2024
1. In this randomized controlled trial, empagliflozin was not shown to decrease the risk of...
Read MoreJun 7, 2024
1. In a cohort of older adults, the use of corticosteroid injections (CSIs) was not associated...
Read MoreJun 6, 2024
1. In this retrospective analysis, compared to nonsmokers, vaping (both within the previous month...
Read MoreJun 6, 2024
1. In this prospective cohort study involving patients with chronic kidney disease (CKD), those...
Read More